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ABSTRACT
Preventive, Predictive, Personalised and Participative (P4)
medicine has the potential to not only vastly improve people’s
quality of life, but also to significantly reduce healthcare costs
and improve its efficiency. Our research focuses on age-related
diseases and explores the opportunities offered by a data-driven
approach to predict wellness states of ageing individuals, in con-
trast to the commonly adopted knowledge-driven approach that
relies on easy-to-interpret metrics manually introduced by clin-
ical experts. This is done by means of machine learning mod-
els applied on the My Smart Age with HIV (MySAwH) dataset,
which is collected through a relatively new approach especially
for older HIV patient cohorts. This includes Patient Related Out-
comes values from mobile smartphone apps and activity traces
from commercial-grade activity loggers. Our results show better
predictive performance for the data-driven approach. We also
show that a post hoc interpretation method applied to the predic-
tive models can provide intelligible explanations that enable new
forms of personalised and preventive medicine.
1 INTRODUCTION
Medical practice is evolving rapidly, away from the traditional but
inefficient detect-and-cure approach, and towards a Preventive,
Predictive, Personalised and Participative (P4) vision that focuses
on extending people’s wellness state, with particular focus on age-
ing individuals [19]. This vision is increasingly data-driven, and
is underpinned by many forms of “Big Health Data” including pe-
riodic clinical assessments and electronic health records, but also
using new forms of self-assessment, such as mobile-based ques-
tionnaires and personal wearable devices. With these premises,
P4 medicine has the potential to not only vastly improve people’s
quality of life, but also to significantly reduce healthcare costs
and improve its efficiency.
Our research explores specific opportunities offered by data-
driven approaches to predictive care, in contrast to traditional,
knowledge-driven approaches that rely purely on clinical ex-
pertise. Our focus is on age-related diseases, an emerging issue
for health care systems. The World Health Organisation esti-
mates that the proportion of people over 60 years of age will
reach 2 billion by 2050 [17]. Ageing is associated with increased
prevalence of co-morbidities that accumulate in the complex of
multi-morbidity in older people [1].
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1.1 Background
We focus on two easy-to-interpret metrics that clinical re-
searchers have proposed to succinctly express the health status
of patients at a given point in time. The first is a measure of
frailty, designed to quantify the reduction of homeostatic reserves
available to an individual. High frailty is indicative of higher
risk of negative health outcomes, but it is also a potentially re-
versible condition [21] In practice, frailty is measured using a
variety of specific Frailty Index metrics (FIs). These are calcu-
lated using at least 30 directly assessed health variables, which
include signs or symptoms, biochemical parameters, various co-
morbidities or socio-demographic data [6, 22]. The choice of the
specific variables, as well as their sources, may vary depending
on data availability, leading to different specifications for the FI.
Given their complexity and multidimensionality, FIs reflect the
biological age of an individual rather than their chronological age,
making them reliable prognostic tools that can be used in differ-
ent settings for clinical decision algorithms [6]. In particular, the
dataset used in this research concerns a cohort of HIV patients.
This is important, because long-lived HIV patients exhibit a form
of accentuated ageing [3],such that they can successfully be used
to study frailty, i.e., where the duration of the condition (number
of years since infection) is used as a proxy for chronological age.
The second measure of health considered in this work directly
reflects the more positive notion of healthy ageing [16] that is
becoming prevalent especially in public health settings. In con-
trast to frailty, which is designed to measure decay, the term
healthy ageing (HA) has been proposed to promote a positive
approach to ageing that relies on reserves and preserved capac-
ities in an individual, rather than accumulation of deficits. In
the World Health Organization Guidelines on Integrated Care
for Older People (ICOPE), HA is based on concrete measures of
Intrinsic Capacity (IC). These are defined as a composite of all
the physical and mental capacities of an individual, divided into
five domains: locomotion, cognition, psychological, vitality and
sensory capacity [16].
As suggested by Belloni and Cesari [2], frailty and IC should
not be considered as two opposed constructs, but rather two
constructs that share a common biological background. The IC
should be considered as an evolution of the frailty concept, taking
into special consideration the functional reserve expressed by
the vitality domain, the need for a worldwide implementation
of prevention, the continuum of the ageing process, and the
opportunities offered by novel technologies [8].
Key to a successful operational definition of IC is the choice
of the variables used to characterise healthy ageing. [16] argues
that integrated care is crucial to incorporate intrinsic capacity
assessment in new care models and encourages the adoption of
wearable devices and mobile apps for longitudinal data collection.
In [9], the authors proposed a self-generated health measure
called Intrinsic Capacity Index (ICI) which relies on physical
function data collected through fitness tracking wearable devices
and a set of electronic Patient-Related Outcomes (PRO) collected
through a dedicated smart-phone app (MySAwH App). In the
study, these variables have been collected longitudinally over a
period of 18 months for a cohort of HIV patients as part of theMy
Smart Age with HIV (MySAwH) study. This is a prospective multi-
center international case-only study, designed to empower Older
People Living With HIV (OPLWH) to achieve healthy lifestyles
and improvement in quality of life.
Similarly to FI, ICI is computed from a subset of the available
variables, by manually selecting a cutoff point for each variable
and simply counting, for a given patient, the variables with value
higher than the cutoff for that patient. We have referred to this
approach that represents the common practice to assess health
condition in geriatric medicine as “knowledge-driven” (KD for
short), as it relies on easy-to-interpret metrics where the choice
of variables and of their cutoff points is defined manually by
clinical experts. The usefulness of the ICI is demonstrated in [9]
by showing experimentally that it displayed higher sensitivity
than FI to predict one central indicator of “wellness state” of
ageing individuals, the Quality of Life (QoL in short).
1.2 Contributions
In contrast to the dominant KD methods as described, in this
paper we explore a complementary data-driven approach (DD)
to predicting wellness states for long-term patients, using a com-
bination of clinical, self-monitoring, and PRO (self-reporting)
longitudinal observations that refer to the five IC domains. As
we will see, while this approach removes the need for the clinical
experts to directly define metrics such as the ICI, it also empow-
ers them by deploying machine learning techniques that make
the predictions easily interpretable.
Specifically, we focus on three dependent variables to charac-
terise the “wellness state” of ageing individuals, namely, (i) Falls,
indicating whether or not a person has experienced any falls
within a given time period; (ii) SPPB, or Short Physical Perfor-
mance Battery, measuring movement of the lower limbs, and (iii)
Quality of Life (QoL). Using the MySAwH dataset for training,
we can directly contrast the DD and KD approaches, and we
show that we can achieve better predictive power without the
need to rely on manually formulated ICI metrics. Furthermore,
we also show that the models’ performance increases if we also
include a single Frailty Index value for each patient, represent-
ing a “baseline” clinical assessment, in addition to the PRO and
activity variables.
Finally, we combine well-established machine learning mod-
els with a post-hoc interpretation method and we show that
satisfactory model performance can be achieved together with
intelligible explanations, which provide the additional benefit of
ranking the variables with respect to a prediction. Indeed, we
show that the relative importance of the variables differs for
each patient, indicating the important role played by intelligible
models towards personalising healthcare. This capability also
provides critical feedback to the clinicians, who can use this in-
formation in combination with their expertise to moderate the
model’s predictions.
2 RELATEDWORK
The idea of exploiting machine learning toward a general “health”
focus is certainly gaining popularity, also thanks to the possi-
bility of continuously monitoring well-being through wearable
activity trackers’ data. For instance, passive sensing techniques
have been recently exploited to assess both mental and physical
health [20] or to predict weight objectives for users of smart
connected devices [26]. Some researchers also successfully ex-
ploited this kind of data in more traditional disease monitoring
scenarios, e.g., to track Multiple Sclerosis [24], depression [29]
and schizophrenia [28] patients’ health. In most of these studies
mobile phones are only exploited as a passive sensing device,
while in our case we combine the use of passive sensing (wear-
able activity tracker) data with self-reporting EMA data collected
through mobile phone apps.
A critical aspect for the successful application of ML to
medicine is the recent increased emphasis on the need for ex-
planations of ML systems [7, 10]. This has lead to another im-
portant research trend, i.e. Interpretable Machine Learning in
healtcare [14]. Even if recent researches have proposed new mod-
els which exhibit high performance as well as interpretability,
e.g., GA2M[15] and rule-based models [25], the utility of these
models in healthcare has not been convincingly demonstrated
yet, due to the rarity of their application [14]. The interpretation
method used in [11, 12], instead, is designed to work with existing
and well established (even if less interpretable) ML methods, such
as gradient boosting or deep learning, by extracting explanations
through models that are applied post-hoc using Shapley Values
[23]. This is one of the most advanced interpretation methods
available, allowing for both global (entire study population) and
local (instance level) explanations. In our study we exploit such
model together with the XGBoost [4] gradient boosting algo-
rithm, in order to aim to both interpretability and performance.
A similar technique has been also proposed, only at conceptual
level, in the Explainable AI framework discussed in [27], which
is however based on clinical-only data analysis.
3 THE HIV COHORT DATASET
The experimental dataset used in this paper was obtained from
the My Smart Age with HIV (MySAwH) [18] project. MySAwH
is a multi-centre prospective ongoing study aiming at empow-
ering OPLWH, i.e. 50+ years old, to develop healthy lifestyles.
The project involves 261 patients from three clinics: 128 from
Modena (Italy), 100 from Sydney (Australia) and 33 from Hong
Kong (China). One novelty of the approach is the combination
of clinical patient data, acquired during periodic scheduled as-
sessments in the clinic, with patient-oriented longitudinal data
about patients’ behavioural, physiological and environmental
health status, which is collected at higher frequency through
smartphones and wearable devices.
Thus, the resulting dataset is highly heterogeneous as to the
data type, the geographical origin of patients and the acquisition
rate. It provides a comprehensive characterization of patients
from the broad determinants of health that impact aging, com-
plemented by those more specific to OPLWH, namely:
Activity tracking variables: Step count, sleep hours and
calories, which are collected daily using a commercial-
grade wearable activity tracker;
PRO variables: 56 categorical questions exploring func-
tional abilities and Quality of life (QoL). These are col-
lected monthly using a dedicated smartphone app;
Clinical variables: Comprehensive geriatric assessment
and HIV-specific variables, which are collected by health-
care workers during study visits at time 0, 9 and 18 months.
37 of these variables were used to measure the Frailty In-
dex (FI) as defined in [6]: 27 from blood tests, 3 about body
composition, 7 HIV-related variables and patient-reported
outcomes.
A preliminary analysis [8] introduced a new index for express-
ing IC, named ICI, and compared the performance of FI and ICI
in predicting QoL. This is a quantitative measure of health as
assessed by the individual respondents that is widely used on
aging population. QoL was assessed using a standardised EQ-5D-
5L questionnaire, based on the EQ Visual Analogue scale (EQ
VAS) [5]. Through the MySAwH dataset, FI and ICI were shown
to be performative tools that can be used in research and clinical
setting to describe disease and health status in OPLWH. ICI score
in comparison to FI displayed higher sensitivity to predict the
QoL and self-perceived health in OPLWH.
Outcomes. In this work, we focus on the task of predicting
significant healty ageing indicators and QoL is one of such in-
dicators. In addition to QoL, two other indicators were selected:
Falls, that is an adverse outcome included among the geriatric
syndroms, and the Short Physical Performance Battery (SPPB),
a group of measures about movement ability with lower limbs
(Guralnik et al., 2000) that can aid in the monitoring of function
in older people. These three outcomes are chosen because they
widely cover all 5 domains of IC. In summary, these are as follows
(Fig. 1 shows their distributions):
Quality of Life (QoL): assessed using the EQ-5D5L stan-
dard, with values between 0 and 1;
Falls: A binary outcome that evaluates to True if a patient
has fallen at least once since the previous visit, and False
otherwise;
SPPB Index: a discrete index that assumes integer values
between 0 and 12.
Observational data and feature space. The observational
dataset used to predict these outcomes covers 18 months and is
broken down into two time windows, reflecting the clinical as-
sessment schedule (months 9 and 18), when the selected clinical
outcomes are assessed. For each time window, we draw two sets
of samples from the related observations, which we are going to
use as ground truth to train our models.
The first consists of the patient-centric longitudinal data, in-
cluding the activity tracking and the PRO variables. To this end,
we further aggregated the resulting PRO time series and the activ-
ity tracking time series at regular intervals of 1 month, resulting
in two sets of data points, one for each of the two windows. The
second sample set augments the first with the FI values com-
puted from the clinical variables measured during hospital visits
at the beginning of each window, namely at times 0 and 9. This
added value is a physician’s assessment that complements the
patient-centric data point and can be interpreted as the baseline
of the time series the data point comes from.
Formally, for each outcome o ∈ {QoL, SPPB, Falls} we write
Sampleo to denote the sample set containing themonthly samples
per patient. For each patient p, we denote a single sample in the
set Sampleo at monthm = i + (j − 1) ∗ 9, corresponding to the
i-th observation, i ∈ [1, 8], in the j-th window, j ∈ [1, 2], by a pair
s
p
m = (xpi , j ,y
p
j ) ∈ Sampleo where
• xpi , j represents the feature vector for i-th observation;
• the feature vector xpi , j contains the values of the PRO and
activity tracking variablesV for patient p at monthm: 56
PRO answers provided by the patient during the corre-
sponding month, i.e. plus 3 aggregated values computed
as the mean of the daily wearable device data (step count,
calories, number of sleep hours) collected during the same
month. Given a variable Vk , x
p
i , j [Vk ] denotes the Vk value
in xpi , j ;
• ypj is the value of the outcome o measured during the
hospital visit at the end of period j.
The second sample set, denoted as SampleF Io , is built by adding
to each feature vector xpi , j ∈ Sampleo , the FI value computed
from the clinical variables measured during the hospital visit at
the beginning of period j , i.e. at month 0 when j = 1 and 9 when
j = 2.
Quality Assurance. Lastly, we performed a quality assurance
step on the resulting sample sets. Within each time window, ob-
servations of PRO variables are sometimes incomplete, resulting
in sequence gaps. The size of the gaps is 5 consecutive missing
observations on average, with a max of 17, and we found 108
gaps per patient on average, with a max of 284 gaps (regardless
of size). We performed imputation by interpolating missing data
points in the time series, with an aim to achieve a balance be-
tween the size of the gaps and the performance of the predictive
model. Clearly, interpolating very large gaps produces spurious
data in the training set. We experimentally determined the max
size of gaps that could be safely interpolated (five missing steps),
by assessing the predictive performance of each of the models re-
sulting from training sets obtained from more or less “aggressive”
interpolation. After adjusting for missing data, the final training
set contains 2,250 data points, with an average of 8 per patient.
The construction of the dataset results in at most 16 samples per
patient, for a total of 4,176 records, considering each month for
each patient.
4 THE LEARNING FRAMEWORK
The objective of the data-driven approach is to predict each out-
come at the time of a visit using the samples referring to the time
window before that visit, as shown in Fig. 2.
To this end, the data-driven learning framework we built is
depicted on the left side of Fig. 3. Each outcome o is predicted by
two learning modelsMo andMF Io , one for each of the two sample
sets Sampleo and SampleF Io , respectively. We trained the two
models separately and assessed the performance using standard
KFold cross-validation (CV) on an 80% of the samples (χtrain )
and a test phase on the remaining 20% samples (χtest ) of the
corresponding sample set.
The DD approach is compared to the KD approach that repre-
sents the common practice in geriatric medicine. To this end, we
built the KD learning framework depicted on the right hand side
of Fig. 3. The approach aims at computing an ICI scores for each
observation by manually selecting a subsetV = {V1 . . .Vn } ⊆ V
of the set of PRO and activity tracking variablesV , specifying
functions si (x) to map each value x for variableVi ∈ V to a score,
and finally combining the individual scores si (x) into a unique
value. The variables are chosen to represent each of the five IC
domains, namely locomotion, cognition, psychological, vitality
and sensory capacity. For most of the variablesVi , a binary score
is defined, i.e., si (x) ∈ {0, 1}, based on a single threshold, for
instance whenVi = stress level (from 1 to 10) the score is mapped
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Figure 1: Distribution of outcomes in the dataset
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Figure 2: Prediction at next clinical visit using only patient
reported outcomes
to 1 if the value is lower than 3 and 0 otherwise. Other variables
are mapped to a score in the [0, 1] range, for instance the number
of steps per day.
Then, given a feature vector xpi , j for patient p, the correspond-
ing ICI value ICI (i, j,p) is computed as the sum of the si (xpi , j [Vi ])
scores, normalised by the number of variables:
ICI (i, j,p) =
∑ |V |
i :1 si (x
p
i , j [Vi ])
n
Such an index is subject to an inevitable bias: the imposition
of the physician’s interpretation on the choice of the variables
of the subset, as well as on the thresholds and the arithmetic
formula to be used.
Also for this case, a dataset consisting exclusively of the ICIs,
Sample ICIo , and one consisting of the ICIs and the FI at the most
recent visit, Sample ICI ,F Io , was isolated. This parallelism with
what was done in the data-driven approach allowed to train
6 learning models with the datasets just described (M ICIo and
M ICI ,F Io for each of the three outcomes o) and to compare the
predictive performances between the two different approaches.
5 EXPERIMENTAL RESULTS AND MODEL
INTERPRETATION
In this section we first discuss the performance of the predictive
models, and then describe in detail our approach and results
regardingmodel interpretation, which is reported as output to the
DD approach in the left side of Fig. 3. The latter is a fundamental
requirement in medicine, where the ability to provide medical
doctors with an easy-to-understand interpretation of the model
predictions is fundamental. This not only conveys confidence in
the predictions, but also helps to make them actionable, i.e., in
the form of recommendations to patients. We present examples
of such interpretations, and their practical relevance, in Sec. 5.2.
The Gradient Boosting algorithm [13] proved to offer better
predictive performance than other popular intelligible learning
frameworks such asGA2M [15], suggesting that separatingmodel
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Figure 3: Comparison between Data-Driven and
Knowledge-Driven approaches
performance from model interpretability would better suit our
needs. Thus, our results are based on a combination of Gradi-
ent Boosting (the XGBoost implementation [4] for performance
(Sec. 5.1), and Shapley Values [23], using the SHAP implemen-
tation [11]) to generate reports on the relative importance of
each individual feature, both across the entire population and for
individual patients (Sec. 5.2).
5.1 Predictive Performance
In our evaluation we compare our DD approach, illustrated in
the left side of Fig. 3, with the KD approach based on a regression
on the IC index (right hand side in the Figure). Fig. 4 shows the
predictive performance of the models we tested, namely: the DD
models trained with and without using FI as a feature, earlier
referred to as MF Io and Mo , respectively; and the KD models,
where again the expert may or may not consider FI. Results are
presented using 1-MAPE (Mean Average Percentage Error) for
the numerical outcomes QoL and SPPB on the left of the figure,
and accuracy, precision, recall and F1 for Falls, on the right.
The results indicate a higher than 90% 1-MAPE for all cases in
QoL and SPPB, while classification accuracy for Falls is higher
than 84%. Further, the DD approach performs generally better
than KD, and both benefit from using FI, with performance reach-
ing 94.3%, 94.9% and 95% for QoL, SPPB, and Falls, respectively.
To note, in one case the KD approach returns a very low
Recall when FI is not used. This can be explained by the strong
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Figure 5: Regression MAE distribution per patient
grouped by clinical center
imbalance of the majority “False” class (no Falls) relative to the
small minority “True”.
The training sets used to generate these models combine pa-
tients from all three clinics. To account for possible differences
in data collection protocols between the clinics, we also created
one separate model for each. The corresponding results are pre-
sented in Table 1 and are consistent with those presented above.
Some anomalies appear in the Hong Kong models, and these are
probably due to the small size of the training set.
Finally, Fig. 5 shows the MAE distribution grouped per clinical
center for QoL and SPPB. This helps understanding the robust-
ness of the models and to identify any non-homogeneity in the
data. In particular, Hong Kong exhibits a higher number of out-
liers compared to Modena and Sydney, probably because of the
small number of cases (33, compared to 128 in Modena and 100
in Sydney), which are also more homogeneous. These results
suggest that developing separate models by stratifying across
clinics and data collection centres may be beneficial for future,
larger scale studies.
5.2 Model Interpretation
SHAP [11] is a framework for interpreting predictions from ma-
chine learning models. It is based on Shapley values, first intro-
duced in 1953 in the context of cooperative game theory [23].
Briefly, the main goal of the framework is to rank the relative
influence of each feature on a predictive model, both locally,
that is, for a specific instance prediction, and globally, i.e., when
considering the model predictions for an entire population.
In our medical setting, this means that for each patient, in
addition to the predicted outcome the clinician also receives a
list of features, ranked in order of their relative importance in
achieving the prediction. Importantly, these orders may differ
for any two patients. This means that, using SHAP, we enable
forms of personalised medicine whereby similar outcomes are
explained in terms of different behaviour, represented for in-
stance by different EMA features. An example appears in Fig. 6,
showing two different sets of positively contributing (green) and
negatively contributing (red) features for two patients with the
same SPPB index (note that, for SPPB, higher is better, as this
indicates the patient’s capacity of physical movement. In the case
of Falls, for instance, the opposite would be true). Clearly, this
added information may lead to different interventions for these
two patients.
At the same time, SHAP provides global explanations, which
characterise the contribution of each feature as a function of its
range of values. For instance, Fig. 7 shows how the SV, indicating
the overall contribution of one of these features (a PRO ques-
tion), goes from negative to positive depending on the patients’
responses to this question, with a definite threshold of ⩾ 3.
We note that this capability essentially mimics the KD ap-
proach in that it identifies thresholds for the variables. While
these are similar to the manually selected cutoffs, in our DD
approach these are automatically identified from the data, in a
principled way. In the future, this explanation capability may un-
derpin epidemiological studies where the precise characterisation
of a populations of individuals enables new forms of preventive
medicine.
6 CONCLUSIONS AND FUTUREWORK
In this paper we have proposed a novel, data-driven approach
towards the definition of Intrinsic Capacity, aimed at quantifying
and predicting the wellness state of old people who live with HIV.
Using a cohort from a multi-centre prospective study as training
set, we have shown that a machine learning model that predicts
three specific wellness metrics (Falls, SPPB, and Quality of Life),
performs equally or better than a manually-defined Intrinsic Ca-
pacity Index. At the same time, the model is interpretable, making
it an ideal complement to expert-based assessment of wellness.
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